RECOVERY / DIRECT CATALOG PRICING
TB-500 / Wolverine Peptide
FDA identifies the substance called TB-500 as the seven-amino-acid thymosin beta-4 fragment LKKTETQ; it is distinct from the full 43-amino-acid thymosin beta-4 protein.
- Format
- Lyophilized research vial
- Listed formats
- 2
- Available now
- 2
- Catalog class
- Recovery
Choose a listed format
- 5 mg$26.00 · AvailableSelect format
- 10 mg$38.00 · AvailableSelect format
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
FDA identifies the substance called TB-500 as the seven-amino-acid thymosin beta-4 fragment LKKTETQ; it is distinct from the full 43-amino-acid thymosin beta-4 protein.
The recovery classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Recovery
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- 2 formats currently orderable
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
FDA identifies the substance called TB-500 as the seven-amino-acid thymosin beta-4 fragment LKKTETQ; it is distinct from the full 43-amino-acid thymosin beta-4 protein.
- Research covered
- Researchers tested full-length thymosin beta-4 and the synthetic LKKTETQ actin-binding fragment in diabetic and aged mouse wound-repair models.
- Important limit
- FDA reports no identified human exposure data for thymosin beta-4 fragment, and the catalog's added name 'Wolverine Peptide' does not further define its chemical identity.
FACTUAL FAQ
TB-500 / Wolverine Peptide catalog questions
What formats are currently listed?
5 mg, 10 mg. Current price and stock state appear above.
What did researchers study?
Researchers tested full-length thymosin beta-4 and the synthetic LKKTETQ actin-binding fragment in diabetic and aged mouse wound-repair models.
What is the most important evidence limit?
FDA reports no identified human exposure data for thymosin beta-4 fragment, and the catalog's added name 'Wolverine Peptide' does not further define its chemical identity.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →